Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report

Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report

Abstract Background Extranodal natural killer/T cell lymphoma, nasal type, is one of the more common subtypes of mature T cell lymphoma, especially in the Far East Asian population. This aggressive histologic subtype of peripheral T cell lymphomas is frequently susceptible to exposure of Epstein–Bar...

Full description

Bibliographic Details
Main Authors: Yao-Chung Liu, Ting-An Lin, Hao-Yuan Wang, Po-Shen Ko, Chia-Jen Liu, Liang-Tsai Hsiao, Sheng-Hsuan Chien, Jyh-Pyng Gau
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Journal of Medical Case Reports
Subjects:
Natural killer/T cell lymphoma
Peripheral T cell lymphoma
Chemotherapy
Pralatrexate
Allogeneic hematopoietic stem cell transplantation
Online Access:http://link.springer.com/article/10.1186/s13256-020-02363-3

Internet

http://link.springer.com/article/10.1186/s13256-020-02363-3

Similar Items